4//SEC Filing
Taveras Arthur 4
Accession 0001628280-24-005379
CIK 0001501697other
Filed
Feb 15, 7:00 PM ET
Accepted
Feb 16, 5:08 PM ET
Size
5.7 KB
Accession
0001628280-24-005379
Insider Transaction Report
Form 4
Taveras Arthur
Chief Scientific Officer
Transactions
- Award
Stock Appreciation Right
2024-02-13+428,248→ 428,248 totalExercise: $0.92Exp: 2034-02-13→ Common Stock (428,248 underlying)
Footnotes (1)
- [F1]The Stock Appreciation Right will vest and become exercisable in equal annual installments (rounding down to the nearest whole share, except for the last installment) on the first, second, and third anniversaries of February 13, 2024, subject to the Reporting Person remaining an employee of the Issuer through and including each applicable vesting date.
Documents
Issuer
X4 Pharmaceuticals, Inc
CIK 0001501697
Entity typeother
Related Parties
1- filerCIK 0001830901
Filing Metadata
- Form type
- 4
- Filed
- Feb 15, 7:00 PM ET
- Accepted
- Feb 16, 5:08 PM ET
- Size
- 5.7 KB